0001022079-19-000090.txt : 20190305
0001022079-19-000090.hdr.sgml : 20190305
20190305162909
ACCESSION NUMBER: 0001022079-19-000090
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190301
FILED AS OF DATE: 20190305
DATE AS OF CHANGE: 20190305
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Doherty Catherine T.
CENTRAL INDEX KEY: 0001520897
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12215
FILM NUMBER: 19658829
MAIL ADDRESS:
STREET 1: C/O QUEST DIAGNOSTICS
STREET 2: 500 PLAZA DRIVE
CITY: SECAUCUS
STATE: NJ
ZIP: 07094
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: QUEST DIAGNOSTICS INC
CENTRAL INDEX KEY: 0001022079
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 161387862
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 500 PLAZA DRIVE
CITY: SECAUCUS
STATE: NJ
ZIP: 07094
BUSINESS PHONE: 9735202700
MAIL ADDRESS:
STREET 1: 500 PLAZA DRIVE
CITY: SECAUCUS
STATE: NJ
ZIP: 07094
FORMER COMPANY:
FORMER CONFORMED NAME: CORNING CLINICAL LABORATORIES INC
DATE OF NAME CHANGE: 19960903
4
1
wf-form4_155182133616795.xml
FORM 4
X0306
4
2019-03-01
0
0001022079
QUEST DIAGNOSTICS INC
DGX
0001520897
Doherty Catherine T.
500 PLAZA DRIVE
SECAUCUS
NJ
07094
0
1
0
0
SVP, Group Exec. Clin. Fran.
Common Stock
2019-03-01
4
A
0
7669
86.86
A
77193
D
Common Stock
2019-03-01
4
F
0
3777
86.86
D
73416
D
Common Stock
3925
I
401(k)/SDCP
Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 25, 2016, approved in accordance with the requirements of Rule 16b-3(d).
Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award.
These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) and/or Supplemental Deferred Compensation Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under each Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date.
/s/ Elena H. Radine, Attorney in Fact for Catherine T. Doherty
2019-03-05